Our study aims to investigate these issues by exploring the connections between IL-17A/F, TLR4, and inflammatory markers, as well as their associations with the severity of steatosis and the likelihood of fibrosis, to identify new biomarkers that could guide future therapeutic strategies. Here, TLR4 is linked to steatosis.